Bicara Therapeutics (BCAX) Enterprise Value (2023 - 2026)
Bicara Therapeutics posted quarterly Enterprise Value of -$539.8 million for Q1 2026, down 16.8% year-on-year from -$648.8 million in Q1 2025, and down 30.12% on a QoQ basis from -$414.8 million in Q4 2025.
Bicara Therapeutics (BCAX) has 4 years of Enterprise Value data on file, last reported at -$539.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 16.8% year-over-year to -$539.8 million; the trailing twelve-month figure through Mar 2026 stood at -$539.8 million (down 16.8% YoY), and the FY2025 full-year result was -$414.8 million, up 15.3% from the prior year.
- Enterprise Value for Q1 2026 stood at -$539.8 million, down from -$414.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$230.4 million in Q4 2023 and bottomed at -$539.8 million in Q1 2026.
- The 4-year median for Enterprise Value is -$449.4 million (2025), against an average of -$423.0 million.
- The widest annual swing landed in 2024, when Enterprise Value tumbled 112.51%; it then surged 44.28% in 2025.
- A 4-year view of Enterprise Value shows it stood at -$230.4 million in 2023, then slumped by 112.51% to -$489.7 million in 2024, then gained by 15.3% to -$414.8 million in 2025, then slumped by 30.12% to -$539.8 million in 2026.
- The last three Enterprise Value figures came in at -$539.8 million (Q1 2026), -$414.8 million (Q4 2025), and -$290.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Bicara Therapeutics | 1.25 Bn | 1.25 Bn | - | -539.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -539.75 Mn |
| Dec 31, 2025 | -414.80 Mn |
| Sep 30, 2025 | -290.17 Mn |
| Jun 30, 2025 | -436.61 Mn |
| Mar 31, 2025 | -462.10 Mn |
| Dec 31, 2024 | -489.71 Mn |
| Sep 30, 2024 | -520.80 Mn |
| Dec 31, 2023 | -230.44 Mn |